Entry Point Capital, LLC Ani Pharmaceuticals Inc Call Options Transaction History
Entry Point Capital, LLC
- $171 Million
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding ANIP
# of Institutions
212Shares Held
18.8MCall Options Held
11.7KPut Options Held
10.5K-
Black Rock Inc. New York, NY2.66MShares$151 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.35MShares$76.7 Million0.0% of portfolio
-
Goldman Sachs Group Inc New York, NY716KShares$40.8 Million0.01% of portfolio
-
State Street Corp Boston, MA704KShares$40.1 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX655KShares$37.3 Million0.01% of portfolio
About ANI PHARMACEUTICALS INC
- Ticker ANIP
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 17,426,000
- Market Cap $992M
- Description
- ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose produc...